Order Article Reprints

Fernández-Salazar L, Campillo A, Rodrigo L, Pérez-Aisa Á, González-Santiago JM, Segarra Ortega X, Denkovski M, Brglez Jurecic N, Bujanda L, Gómez Rodríguez BJ, et al. Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacterpylori Infection (Hp-EuReg). Journal of Clinical Medicine. 2022; 11(12):3544. https://doi.org/10.3390/jcm11123544

Fernández-Salazar, Luis, Ana Campillo, Luis Rodrigo, Ángeles Pérez-Aisa, Jesús M. González-Santiago, Xavier Segarra Ortega, Maja Denkovski, Natasa Brglez Jurecic, Luis Bujanda, Blas José Gómez Rodríguez, and et al. 2022. "Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacterpylori Infection (Hp-EuReg)" Journal of Clinical Medicine 11, no. 12: 3544. https://doi.org/10.3390/jcm11123544

Fernández-Salazar, L., Campillo, A., Rodrigo, L., Pérez-Aisa, Á., González-Santiago, J. M., Segarra Ortega, X., Denkovski, M., Brglez Jurecic, N., Bujanda, L., Gómez Rodríguez, B. J., Ortuño, J., Georgopoulos, S., Jonaitis, L., Puig, I., Nyssen, O. P., Megraud, F., O’Morain, C., & Gisbert, J. P. (2022). Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacterpylori Infection (Hp-EuReg). Journal of Clinical Medicine, 11(12), 3544. https://doi.org/10.3390/jcm11123544